Total Payments
$11,195
2024 Payments
$2,697
Companies
31
Transactions
640
Medicare Patients
6,651
Medicare Billing
$708,234
Payment Breakdown by Category
Food & Beverage$10,574 (94.5%)
Consulting$430.00 (3.8%)
Education$190.76 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,574 | 635 | 94.5% |
| Consulting Fee | $430.00 | 1 | 3.8% |
| Education | $190.76 | 4 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,458 | 74 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,078 | 27 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,013 | 67 | $0 (2024) |
| Lilly USA, LLC | $755.24 | 33 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $753.48 | 32 | $0 (2024) |
| PFIZER INC. | $667.05 | 14 | $0 (2024) |
| Incyte Corporation | $640.08 | 14 | $0 (2024) |
| GENZYME CORPORATION | $562.74 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $536.52 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $533.61 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,697 | 138 | ABBVIE INC. ($550.86) |
| 2023 | $2,280 | 112 | Incyte Corporation ($527.68) |
| 2022 | $885.19 | 48 | ABBVIE INC. ($212.57) |
| 2021 | $1,042 | 128 | VYNE Pharmaceuticals Inc. ($242.44) |
| 2020 | $1,001 | 114 | VYNE Pharmaceuticals Inc. ($218.58) |
| 2019 | $2,084 | 87 | Galderma Laboratories, L.P. ($503.74) |
| 2018 | $652.64 | 8 | Galderma Laboratories, L.P. ($146.06) |
| 2017 | $554.75 | 5 | PFIZER INC. ($456.27) |
All Payment Transactions
640 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $126.47 | General |
| 12/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $7.39 | General |
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Immunology | ||||||
| 11/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.10 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology | ||||||
| 11/14/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.08 | General |
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,699 | 3,605 | $597,711 | $194,561 |
| 2022 | 19 | 1,792 | 3,406 | $467,175 | $159,931 |
| 2021 | 20 | 1,702 | 3,231 | $895,357 | $199,406 |
| 2020 | 17 | 1,458 | 2,991 | $529,097 | $154,336 |
Total Patients
6,651
Total Services
13,233
Medicare Billing
$708,234
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 248 | 411 | $89,187 | $25,120 | 28.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 47 | 71 | $55,516 | $21,760 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 230 | 319 | $59,334 | $19,944 | 33.6% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 31 | 224 | $56,000 | $19,780 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 142 | $35,926 | $13,157 | 36.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 154 | 318 | $34,980 | $11,677 | 33.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 61 | 93 | $31,899 | $10,971 | 34.4% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 36 | 48 | $29,088 | $9,708 | 33.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 215 | 316 | $42,976 | $8,975 | 20.9% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 16 | 36 | $19,944 | $7,357 | 36.9% |
| 96920 | Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | Office | 2023 | 13 | 60 | $20,340 | $7,002 | 34.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 100 | $23,600 | $6,845 | 29.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 170 | 1,074 | $15,036 | $4,942 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $13,260 | $4,717 | 35.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 18 | 20 | $10,980 | $4,026 | 36.7% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 21 | 28 | $11,172 | $3,867 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $11,172 | $3,585 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 76 | $8,740 | $2,992 | 34.2% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 27 | 93 | $8,370 | $2,882 | 34.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 36 | 36 | $5,364 | $1,596 | 29.7% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 20 | 24 | $7,800 | $1,424 | 18.3% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 13 | 13 | $3,952 | $1,386 | 35.1% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 15 | $3,075 | $848.16 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 264 | 354 | $76,818 | $24,901 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 262 | $48,732 | $17,538 | 36.0% |
About Dr. Michael Meyer, M.D
Dr. Michael Meyer, M.D is a Procedural Dermatology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1477964005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Meyer, M.D has received a total of $11,195 in payments from pharmaceutical and medical device companies, with $2,697 received in 2024. These payments were reported across 640 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,574).
As a Medicare-enrolled provider, Meyer has provided services to 6,651 Medicare beneficiaries, totaling 13,233 services with total Medicare billing of $708,234. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Dermatology
- Location Plano, TX
- Active Since 05/16/2014
- Last Updated 08/01/2025
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477964005
Products in Payments
- DUPIXENT (Biological) $834.36
- SKYRIZI (Biological) $723.97
- TALTZ (Drug) $615.71
- EUCRISA (Drug) $538.31
- RINVOQ (Biological) $508.32
- TREMFYA (Drug) $490.98
- Otezla (Drug) $458.71
- ILUMYA (Biological) $422.24
- COSENTYX (Biological) $303.41
- ZILXI (Drug) $291.17
- EPIDUO FORTE (Drug) $252.08
- Sotyktu (Drug) $244.62
- BLU-U (Medical Supply) $231.43
- Cimzia (Drug) $230.68
- DUPIXENT (Drug) $222.92
- OPZELURA (Drug) $210.08
- COSENTYX (Drug) $205.67
- VTAMA (Drug) $204.18
- SOOLANTRA (Drug) $193.94
- Zoryve (Drug) $182.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.